{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:09:49Z","timestamp":1791295789415,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1717,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ajpath.2014.11.029","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T04:15:13Z","timestamp":1425874513000},"page":"1022-1032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Transcriptomic Analysis Predicts Survival and Sensitivity to Anticancer Drugs of Patients with a Pancreatic Adenocarcinoma"],"prefix":"10.1016","volume":"185","author":[{"given":"Pauline","family":"Duconseil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Gilabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Gayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Loncle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Moutardier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Turrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Ewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Gasmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Bories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Barthet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ouaissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Poizat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Luc","family":"Raoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Secq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Viens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Iovanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Dusetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2014.11.029_bib1","first-page":"5","article-title":"Cancer statistics, 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2014.11.029_bib2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(11)70004-3","article-title":"Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study","volume":"12","author":"Kindler","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib3","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"National Cancer Institute of Canada Clinical Trials G: Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib4","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1200\/JCO.2008.20.0238","article-title":"Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer","volume":"27","author":"Van Cutsem","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrgastro.2012.119","article-title":"New biomarkers and targets in pancreatic cancer and their application to treatment","volume":"9","author":"Costello","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2014.11.029_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fonc.2012.00006","article-title":"Current knowledge on pancreatic cancer","volume":"2","author":"Iovanna","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"Groupe Tumeurs Digestives of U, Intergroup P: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajpath.2014.11.029_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gut.2010.226092","article-title":"Stromal biology and therapy in pancreatic cancer","volume":"60","author":"Neesse","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2014.11.029_bib10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.gastro.2004.03.058","article-title":"Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene","volume":"127","author":"Schreiber","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.11.029_bib11","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1021\/bi00591a005","article-title":"Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease","volume":"18","author":"Chirgwin","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpath.2014.11.029_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"10.1016\/j.ajpath.2014.11.029_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/gm544","article-title":"Transcriptional dissection of pancreatic tumors engrafted in mice","volume":"6","author":"Martinez-Garcia","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.ajpath.2014.11.029_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1349-7006.2005.00064.x","article-title":"Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells","volume":"96","author":"Ishikawa","year":"2005","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2014.11.029_bib15","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1038\/sj.onc.1208804","article-title":"Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions","volume":"24","author":"Buchholz","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2014.11.029_bib16","doi-asserted-by":"crossref","first-page":"12890","DOI":"10.1073\/pnas.0705505104","article-title":"Transcriptional network governing the angiogenic switch in human pancreatic cancer","volume":"104","author":"Abdollahi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2014.11.029_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/path.2524","article-title":"Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas","volume":"218","author":"Cavard","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib18","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/1535-7163.MCT-08-0755","article-title":"Consensus transcriptome signature of perineural invasion in pancreatic carcinoma","volume":"8","author":"Abiatari","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ajpath.2014.11.029_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2012.01.036","article-title":"Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL-1beta in human pancreatic cancer cells: role of JNK","volume":"320","author":"Verma","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2014.11.029_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1158\/2159-8290.CD-11-0224","article-title":"Essential gene profiles in breast, pancreatic, and ovarian cancer cells","volume":"2","author":"Marcotte","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2014.11.029_bib21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1053\/j.gastro.2013.07.040","article-title":"A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression","volume":"145","author":"Wang","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.11.029_bib22","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1158\/1078-0432.CCR-05-1274","article-title":"Specialized DNA arrays for the differentiation of pancreatic tumors","volume":"11","author":"Buchholz","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2014.11.029_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<97::AID-GCC5>3.0.CO;2-V","article-title":"Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis","volume":"19","author":"Gress","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ajpath.2014.11.029_bib24","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1038\/sj.onc.1205570","article-title":"Expression profiling of microdissected pancreatic adenocarcinomas","volume":"21","author":"Crnogorac-Jurcevic","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2014.11.029_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm.2344","article-title":"Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy","volume":"17","author":"Collisson","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2014.11.029_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/meth.2001.1263","article-title":"Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies","volume":"25","author":"Lehmann","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ajpath.2014.11.029_bib27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1091-255X(00)80105-5","article-title":"Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators","volume":"4","author":"Sohn","year":"2000","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ajpath.2014.11.029_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9610(05)80406-4","article-title":"Prognostic indicators for survival after resection of pancreatic adenocarcinoma","volume":"165","author":"Geer","year":"1993","journal-title":"Am J Surg"},{"key":"10.1016\/j.ajpath.2014.11.029_bib29","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s11605-009-0969-5","article-title":"Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma","volume":"13","author":"You","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ajpath.2014.11.029_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/01.mpa.0000194609.24606.4b","article-title":"Predicting survival after surgical resection for pancreatic ductal adenocarcinoma","volume":"32","author":"Moon","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.ajpath.2014.11.029_bib31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00000478-200207000-00007","article-title":"Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors","volume":"26","author":"Yantiss","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib32","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1245\/s10434-010-1071-7","article-title":"Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging?","volume":"17","author":"Wasif","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib33","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1245\/s10434-013-3159-3","article-title":"Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system","volume":"20","author":"Rochefort","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib34","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1158\/1078-0432.CCR-12-1215","article-title":"Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors","volume":"18","author":"Yachida","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2014.11.029_bib35","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1158\/1078-0432.CCR-11-0341","article-title":"Tumor engraftment in nude mice and enrichment in stroma-related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer","volume":"17","author":"Garrido-Laguna","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2014.11.029_bib36","first-page":"4","article-title":"Oxaliplatin: mechanism of action and antineoplastic activity","volume":"25","author":"Raymond","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib37","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1440-1681.1998.tb02339.x","article-title":"5-fluorouracil: a pharmacological paradigm in the use of cytotoxics","volume":"25","author":"Thomas","year":"1998","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ajpath.2014.11.029_bib38","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1158\/1078-0432.CCR-11-3112","article-title":"Heterogeneity and targeting of pancreatic cancer stem cells","volume":"18","author":"Penchev","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2014.11.029_bib39","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1158\/1078-0432.CCR-12-2127","article-title":"Personalized chemotherapy profiling using cancer cell lines from selectable mice","volume":"19","author":"Kamiyama","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2014.11.029_bib40","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1158\/1078-0432.CCR-12-0827","article-title":"Genetically defined subsets of human pancreatic cancer show unique in\u00a0vitro chemosensitivity","volume":"18","author":"Cui","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:45:16Z","timestamp":1757601916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944015000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0002944015000644"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.11.029","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic Analysis Predicts Survival and Sensitivity to Anticancer Drugs of Patients with a Pancreatic Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}